As of December 31, 2025, Immuron Limited carries a market capitalization of 4.56M, placing it among publicly traded companies globally. Its enterprise value stands at -1.12M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 4.56M |
| Enterprise Value | -1.12M |
Immuron Limited's next confirmed earnings release is scheduled for February 19, 2027.
| Earnings Date | 2/19/2027 |
As of December 31, 2025, Immuron Limited has 326.65M shares outstanding.
| Shares Outstanding | 326.65M |
These figures are as of December 31, 2025.
| PB Ratio | 0.61 |
| P/TBV Ratio | 0.61 |
As of December 31, 2025, Immuron Limited maintains a current ratio of 8.04, meaning it holds 8.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 8.04 |
| Quick Ratio | 6.75 |
As of the close on October 22, 2026, Immuron Limited's stock has declined approximately 34.09% over the past 52 weeks. The 50-day moving average sits at 0.03, while the 200-day moving average is 0.02.
| 52-Week Price Change | -34.09% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.02 |
These figures are as of December 31, 2025. Total book value stands at 7.43M, with working capital of 7.42M providing operational flexibility.
| Cash & Cash Equivalents | 5.68M |
| Net Debt | -5.68M |
| Equity (Book Value) | 7.43M |
| Book Value Per Share | 0.02 |
| Working Capital | 7.42M |
Immuron Limited's most recent stock split took place on June 2, 2016.
| Last Split Date | 6/2/2016 |
Already premium?